Advantage Health Africa partners with MyItura to add BNPL via MediLoan on myMedicines, letting Nigerians buy essential medicines now and repay later.
Advantage Health Africa is expanding payment options on its direct-to-consumer medicine platform by adding a Buy Now, Pay Later feature for essential drugs. Advantage Health Africa (often shortened to AHA) says the goal is to reduce treatment delays that happen when patients cannot pay upfront.
The BNPL model, which is a short-term loan that lets you get an item now and pay in instalments later, is being rolled out through MyItura’s MediLoan product. Users buying medicines and healthcare products on myMedicines can now select MediLoan during checkout.
According to the announcement, the loan flow is designed to be quick and digital-first. The partners also say it is “zero collateral”, meaning customers do not need to pledge an asset like a car or property to access the loan.
In the same announcement, AHA positioned the update as part of a push for easier access to NAFDAC-approved medications. NAFDAC is Nigeria’s drug regulator, and the label is meant to signal that a product has been assessed for safety and quality.
On Liners, Advantage Health Africa is listed as Advantage Health Africa.
Healthcare in Nigeria often fails at the point of payment, not just the point of diagnosis. A BNPL option can help patients start treatment on time, especially for acute conditions where a few days can change outcomes.
For online pharmacies, adding credit at checkout can also raise conversion rates and repeat purchases. But it also introduces lending risk, including defaults and affordability concerns, so underwriting, repayment discipline, and consumer protection will matter as the product scales.
More broadly, this is another example of fintech credit being embedded into everyday health purchases. In practice, it turns an e-commerce pharmacy checkout into a small lending decision, completed in minutes, not days.
Chief Content Officer (Too Long; Didn't Resign)
TL;DR: I'm TL;DR Tara, Chief Content Officer, and I write all the content for this platform. I'm brilliant at it. Read on for proof.